NCT03245021 Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03241264 A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the Body Status COMPLETED Phase PHASE1
NCT03241186 Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03238365 Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck Status COMPLETED Phase EARLY_PHASE1
NCT03227432 An Exploratory Study to Evaluate the Combination of Elotuzumab and Nivolumab With and Without Pomalidomide in Relapsed Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT03225716 A Study of Ulocuplumab And Ibrutinib in Symptomatic Patients With Mutated CXCR4 Waldenstrom's Macroglobulinemia Status TERMINATED Phase PHASE1
NCT03224260 To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants Status COMPLETED Phase PHASE1
NCT03219775 Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Transitional Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT03215927 Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease Status COMPLETED Phase PHASE2
NCT03215810 Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT03215706 A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC Status COMPLETED Phase PHASE3
NCT03214250 Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT03210909 Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT03208322 Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic Hepatitis C (CHC) in Adults Status WITHDRAWN Phase N/A
NCT03205722 The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany Status WITHDRAWN Phase N/A
NCT03205618 A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and Qatar Status COMPLETED Phase N/A